학술논문

Oncogenic KRAS, Mucin 4, and Activin A‐Mediated Fibroblast Activation Cooperate for PanIN Initiation
Document Type
article
Source
Advanced Science. 10(36)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Cancer
Genetics
Digestive Diseases
Pancreatic Cancer
Prevention
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Mice
Humans
Animals
Proto-Oncogene Proteins p21(ras)
Mucin-4
Pancreatic Neoplasms
Carcinoma
Pancreatic Ductal
Mice
Transgenic
Carcinoma in Situ
alpha SMA(+) fibroblast
activin A
PanIN
Kras
Muc4
αSMA+ fibroblast
Language
Abstract
Over 90% of patients with pancreatic ductal adenocarcinoma (PDAC) have oncogenic KRAS mutations. Nevertheless, mutated KRAS alone is insufficient to initiate pancreatic intraepithelial neoplasia (PanIN), the precursor of PDAC. The identities of the other factors/events required to drive PanIN formation remain elusive. Here, optic-clear 3D histology is used to analyze entire pancreases of 2-week-old Pdx1-Cre; LSL-KrasG12D/+ (KC) mice to detect the earliest emergence of PanIN and observed that the occurrence is independent of physical location. Instead, it is found that the earliest PanINs overexpress Muc4 and associate with αSMA+ fibroblasts in both transgenic mice and human specimens. Mechanistically, KrasG12D/+ pancreatic cells upregulate Muc4 through genetic alterations to increase proliferation and fibroblast recruitments via Activin A secretion and consequently enhance cell transformation for PanIN formation. Inhibition of Activin A signaling using Follistatin (FST) diminishes early PanIN-associated fibroblast recruitment, effectively curtailing PanIN initiation and growth in KC mice. These findings emphasize the vital role of interactions between oncogenic KrasG12D/+ -driven genetic alterations and induced microenvironmental changes in PanIN initiation, suggesting potential avenues for early PDAC diagnostic and management approaches.